 |
 |

Discontinuance of Immunosuppression in Renal Transplant Patients
Milton L. Owens, MD;
J. Gary Maxwell, MD;
James Goodnight, MD;
Mark W. Wolcott, MD
Arch Surg. 1975;110(12):1450-1451.
Abstract
Immunosuppressive therapy was discontinued in six patients for an average of 27 months. In these six patients, only two rejections have occurred. A survey of other transplant centers showed that in such patients rejection was often delayed weeks or months after therapy was stopped. Once immunosuppressive therapy has been stopped, for whatever reason, and rejection has not occurred, consideration should be given to not resuming therapy unless signs of rejection appear.
(Arch Surg 110:1450-1451, 1975)
Author Affiliations
From the departments of surgery, Wadsworth Veterans Administration Hospital, Los Angeles (Dr Owens) and the University of Utah Medical Center, Salt Lake City (Drs Maxwell, Goodnight, and Wolcott).
Footnotes
Accepted for publication March 31, 1975.
Reprint requests to Department of Surgery, Wadsworth Veterans Administration Hospital, Wilshire and Swatelle boulevards, Los Angeles, CA 90073 (Dr Owens).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Frontiers in Nephrology: Immune Tolerance to Allografts in Humans
Girlanda and Kirk
J. Am. Soc. Nephrol. 2007;18:2242-2251.
ABSTRACT
| FULL TEXT
Is Noncompliance Among Adolescent Renal Transplant Recipients Inevitable?
Feinstein et al.
Pediatrics 2005;115:969-973.
ABSTRACT
| FULL TEXT
Payment for Immunosuppression After Organ Transplantation
Kasiske et al.
JAMA 2000;283:2445-2450.
ABSTRACT
| FULL TEXT
|